Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (48) 48
life sciences & biomedicine (44) 44
humans (37) 37
male (28) 28
female (26) 26
biological and medical sciences (21) 21
aged (19) 19
middle aged (18) 18
adult (14) 14
medical sciences (14) 14
oncology (11) 11
fundamental and applied biological sciences. psychology (9) 9
treatment outcome (9) 9
abridged index medicus (7) 7
italy (7) 7
obstetrics and gynecology (7) 7
pregnancy (7) 7
time factors (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
cancer (6) 6
disease-free survival (6) 6
kaplan-meier estimate (6) 6
tumors (6) 6
adolescent (5) 5
aged, 80 and over (5) 5
agriculture (5) 5
animals (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
child (5) 5
delirium (5) 5
drug therapy (5) 5
genetics & heredity (5) 5
multiple myeloma - drug therapy (5) 5
obstetrics & gynecology (5) 5
pharmacology. drug treatments (5) 5
retrospective studies (5) 5
soil science (5) 5
thalidomide - administration & dosage (5) 5
young adult (5) 5
administration, oral (4) 4
agronomy. soil science and plant productions (4) 4
health aspects (4) 4
hematology (4) 4
hematology, oncology and palliative medicine (4) 4
immunodeficiencies. immunoglobulinopathies (4) 4
immunoglobulinopathies (4) 4
immunopathology (4) 4
italy - epidemiology (4) 4
medicine & public health (4) 4
meta-analysis (4) 4
molecular and cellular biology (4) 4
mutation (4) 4
neurosciences & neurology (4) 4
patients (4) 4
pharmacology & pharmacy (4) 4
research (4) 4
statistics (4) 4
urology (4) 4
alkyl and aryl transferases - antagonists & inhibitors (3) 3
anticoagulants - administration & dosage (3) 3
anticoagulants - therapeutic use (3) 3
anticonvulsants - therapeutic use (3) 3
antineoplastic agents - therapeutic use (3) 3
automation (3) 3
boronic acids - administration & dosage (3) 3
bortezomib (3) 3
care and treatment (3) 3
cerebrospinal fluid (3) 3
chemotherapy, adjuvant (3) 3
clinical neurology (3) 3
cytofluorimeter (3) 3
delirium - epidemiology (3) 3
dexamethasone - administration & dosage (3) 3
epilepsy (3) 3
exact sciences and technology (3) 3
farnesyltranstransferase (3) 3
fetal growth restriction (3) 3
general & internal medicine (3) 3
infant, newborn (3) 3
internal medicine (3) 3
life sciences (3) 3
logistic models (3) 3
medicine (3) 3
medicine, general & internal (3) 3
meningitis (3) 3
mental disorders (3) 3
multiple myeloma - surgery (3) 3
pharmacology/toxicology (3) 3
physical sciences (3) 3
positron emission tomography (3) 3
prevalence (3) 3
psychiatry (3) 3
pyrazines - administration & dosage (3) 3
pyrimidines - therapeutic use (3) 3
recurrence (3) 3
remission induction (3) 3
soil science & conservation (3) 3
soils (3) 3
studies (3) 3
transplantation, autologous (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text High‐mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair
by Bianchi, Marco E and Crippa, Massimo P and Manfredi, Angelo A and Mezzapelle, Rosanna and Rovere Querini, Patrizia and Venereau, Emilie
Immunological reviews, ISSN 0105-2896, 11/2017, Volume 280, Issue 1, pp. 74 - 82
damage associate molecular pattern (DAMP) | innate immunity | inflammation | immunogenic cell death (ICD) | adaptive immunity | tissue repair | Life Sciences & Biomedicine | Immunology | Science & Technology | Adaptive Immunity | Animals | Oxidation-Reduction | Humans | Cell Death | DNA Damage - immunology | HMGB1 Protein - immunology | Inflammation - immunology | Wound Healing | Immunity, Innate | Inflammation | Chromosomal proteins | Cell death | Stem cells | Cell proliferation | Lysosomes | Macrophages | Tissues | Nuclei | Immunity | HMGB1 protein | Proteins | Receptors | Cell activation | Moisture content | Oxidation | Repair | Immune system | Antigens | Immunological memory | Immune response | Adaptive immunity | Switching | Damage patterns | Immunogenicity | Healing | Cytoplasm | Tumors | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
by Cavo, Michele, Prof and Tacchetti, Paola, MD and Patriarca, Francesca, MD and Petrucci, Maria Teresa, MD and Pantani, Lucia, MD and Galli, Monica, MD and Di Raimondo, Francesco, Prof and Crippa, Claudia, MD and Zamagni, Elena, MD and Palumbo, Antonio, MD and Offidani, Massimo, MD and Corradini, Paolo, Prof and Narni, Franco, MD and Spadano, Antonio, MD and Pescosta, Norbert, MD and Deliliers, Giorgio Lambertenghi, Prof and Ledda, Antonio, MD and Cellini, Claudia, MD and Caravita, Tommaso, MD and Tosi, Patrizia, MD and Baccarani, Michele, Prof and for the GIMEMA Italian Myeloma Network and GIMEMA Italian Myeloma Network
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9758, pp. 2075 - 2085
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Immunopathology | General aspects | Pharmacology. Drug treatments | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Multiple Myeloma - drug therapy | Adult | Female | Boronic Acids - administration & dosage | Chemotherapy, Adjuvant | Multiple Myeloma - surgery | Thalidomide - adverse effects | Reoperation | Bortezomib | Dexamethasone - administration & dosage | Drug Administration Schedule | Multiple Myeloma - diagnosis | Kaplan-Meier Estimate | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Thalidomide - administration & dosage | Remission Induction | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Pyrazines - adverse effects | Italy | Aged | Complications and side effects | Dexamethasone | Multiple myeloma | Dosage and administration | Drug therapy | Thalidomide | Studies | Heart failure | Consolidation | Heart attacks | Data collection | Clinical medicine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial
by Necchi, Andrea, Dr and Mariani, Luigi, MD and Zaffaroni, Nadia, PhD and Schwartz, Lawrence H, MD and Giannatempo, Patrizia, MD and Crippa, Flavio, MD and Morosi, Carlo, MD and Lanocita, Rodolfo, MD and Sava, Teodoro, MD and Ortega, Cinzia, MD and Messina, Caterina, MD and Sacco, Cosimo, MD and Pennati, Marzia, PhD and Daidone, Maria G, PhD and Nicolai, Nicola, MD and De Braud, Filippo, MD and Gianni, Alessandro M, Prof and Salvioni, Roberto, MD
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 8, pp. 810 - 816
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Urothelium - pathology | Urologic Neoplasms - pathology | Angiogenesis Inhibitors - administration & dosage | Urologic Neoplasms - drug therapy | Time Factors | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Risk Assessment | Administration, Oral | Pyrimidines - administration & dosage | Urologic Neoplasms - mortality | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Linear Models | Treatment Outcome | Tumor Burden | Disease-Free Survival | Cisplatin - therapeutic use | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Italy | Aged | Urothelium - drug effects | Sulfonamides - administration & dosage | Care and treatment | Endothelial growth factors | Oncology, Experimental | Research | Angiogenesis inhibitors | Vascular endothelial growth factor | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Pattern of pore water nutrients in planted and non-planted soilless substrates as affected by the addition of biochars from wood gasification
by Bedussi, Floriana and Zaccheo, Patrizia and Crippa, Laura
Biology and fertility of soils, ISSN 0178-2762, 7/2015, Volume 51, Issue 5, pp. 625 - 635
Life Sciences | NH 4 + -N | NO 3 – -N | Pore water | Agriculture | Biochar | Peat | Potassium | Soil Science & Conservation | Soil Science | Life Sciences & Biomedicine | Science & Technology | Water | Organic fertilizers | Ammonia | Studies | Nutrients | Peatlands
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
by Marco Ladetto and Gloria Pagliano and Simone Ferrero and Federica Cavallo and Daniela Drandi and Loredana Santo and Claudia Crippa and Luca De Rosa and Patrizia Pregno and Mariella Grasso and Anna Marina Liberati and Tommaso Caravita and Francesco Pisani and Tommasina Guglielmelli and Vincenzo Callea and Pellegrino Musto and Clotilde Cangialosi and Roberto Passera and Mario Boccadoro and Antonio Palumbo
Journal of clinical oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 12, pp. 2077 - 2084
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Pyrazines - administration & dosage | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Genes, Immunoglobulin Heavy Chain | Neoplasm, Residual | Stem Cell Transplantation | Multiple Myeloma - drug therapy | Time Factors | Polymerase Chain Reaction | Adult | Female | Boronic Acids - administration & dosage | Chemotherapy, Adjuvant | Multiple Myeloma - surgery | Bortezomib | Dexamethasone - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Thalidomide - administration & dosage | Chi-Square Distribution | Disease-Free Survival | Multiple Myeloma - pathology | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Italy | Aged | Multiple Myeloma - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
by Antonio Palumbo and Michele Cavo and Sara Bringhen and Elena Zamagni and Alessandra Romano and Francesca Patriarca and Davide Rossi and Fabiana Gentilini and Claudia Crippa and Monica Galli and Chiara Nozzoli and Roberto Ria and Roberto Marasca and Vittorio Montefusco and Luca Baldini and Francesca Elice and Vincenzo Callea and Stefano Pulini and Angelo M. Carella and Renato Zambello and Giulia Benevolo and Valeria Magarotto and Paola Tacchetti and Norbert Pescosta and Claudia Cellini and Claudia Polloni and Andrea Evangelista and Tommaso Caravita and Fortunato Morabito and Massimo Offidani and Patrizia Tosi and Mario Boccadoro
Journal of clinical oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 8, pp. 986 - 993
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunopathology | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Tumors | Multiple Myeloma - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Warfarin - adverse effects | Male | Antineoplastic Agents - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Warfarin - therapeutic use | Fibrinolytic Agents - adverse effects | Multiple Myeloma - drug therapy | Thromboembolism - prevention & control | Time Factors | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Cardiovascular Diseases - mortality | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Cardiovascular Diseases - etiology | Risk Assessment | Multiple Myeloma - complications | Risk Factors | Anticoagulants - therapeutic use | Treatment Outcome | Thromboembolism - etiology | Thromboembolism - mortality | Thalidomide - administration & dosage | Anticoagulants - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy | Aged | Hemorrhage - chemically induced | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network
by Antonio Palumbo and Patrizia Falco and Paolo Corradini and Antonietta Falcone and Francesco Di Raimondo and Nicola Giuliani and Claudia Crippa and Giovannino Ciccone and Paola Omedè and Maria Teresa Ambrosini and Francesca Gay and Sara Bringhen and Pellegrino Musto and Robin Foà and Robert Knight and Jerome B. Zeldis and Mario Boccadoro and Maria Teresa Petrucci and GIMEMA--Italian Multiple Myeloma Network
Journal of clinical oncology, ISSN 0732-183X, 10/2007, Volume 25, Issue 28, pp. 4459 - 4465
Immunopathology | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Tumors | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Thalidomide - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Melphalan - adverse effects | Drug-Related Side Effects and Adverse Reactions | Female | Melphalan - pharmacology | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Administration, Oral | Thalidomide - administration & dosage | Maximum Tolerated Dose | Melphalan - administration & dosage | Multiple Myeloma - pathology | Survival Analysis | Prednisone - pharmacology | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma Patients
by Antonio Palumbo and Francesca Gay and Patrizia Falco and Claudia Crippa and Vittorio Montefusco and Francesca Patriarca and Fausto Rossini and Simona Caltagirone and Giulia Benevolo and Norbert Pescosta and Tommasina Guglielmelli and Sara Bringhen and Massimo Offidani and Nicola Giuliani and Maria Teresa Petrucci and Pellegrino Musto and Anna Marina Liberati and Giuseppe Rossi and Paolo Corradini and Mario Boccadoro
Journal of clinical oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 800 - 807
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunopathology | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Tumors | Multiple Myeloma - mortality | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Stem Cell Transplantation | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Time Factors | Doxorubicin - analogs & derivatives | Protease Inhibitors - administration & dosage | Female | Neoadjuvant Therapy | Boronic Acids - administration & dosage | Chemotherapy, Adjuvant | Multiple Myeloma - surgery | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Bortezomib | Dexamethasone - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Thalidomide - administration & dosage | Polyethylene Glycols - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy - epidemiology | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Ammonium nutrition as a strategy for cadmium mobilisation in the rhizosphere of sunflower
by Patrizia Zaccheo and Laura Crippa and Valeria Di Muzio Pasta
Plant and soil, ISSN 0032-079X, 5/2006, Volume 283, Issue 1/2, pp. 43 - 56
Quaternary ammonium compounds | Agricultural soils | Plant roots | Plants | Acid soils | Soil pollution | Soil acidification | Silty soils | Sunflowers | Life Sciences | nitrogen fertilisers | cadmium | DMPP | phytoextraction | Ecology | Plant Physiology | Plant Sciences | sunflower | Soil Science & Conservation | rhizosphere acidification | Cadmium | Nitrogen fertilisers | Sunflower | Rhizosphere acidification | Phytoextraction | Nutrition | Soils | Flowers & plants
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis
by van Oostwaard, Miriam F., MD and Langenveld, Josje, MD, PhD and Schuit, Ewoud, MSc, PhD and Papatsonis, Dimitri N.M., MD, PhD and Brown, Mark A., MD, PhD and Byaruhanga, Romano N., MD, PhD and Bhattacharya, Sohinee, MD, PhD and Campbell, Doris M., MD, PhD and Chappell, Lucy C., MD, PhD and Chiaffarino, Francesca, ScD and Crippa, Isabella, MD, PhD and Facchinetti, Fabio, MD, PhD and Ferrazzani, Sergio, MD, PhD and Ferrazzi, Enrico, MD, PhD and Figueiró-Filho, Ernesto A., MD, PhD and Gaugler-Senden, Ingrid P.M., MD, PhD and Haavaldsen, Camilla, MD, PhD and Lykke, Jacob A., MD, PhD and Mbah, Alfred K., PhD and Oliveira, Vanessa M., MD, PhD and Poston, Lucilla, MD, PhD and